Milan, Italy and Houston, TX, October 9, 2015 - Sorin S.p.A. (MTA; Reuters Code: SORN.MI) ('Sorin'), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ: CYBX, 'Cyberonics'), a medical device company with core expertise in neuromodulation, today announced the two remaining designees to the Board of Directors of the combined company, LivaNova PLC ('LivaNova'), effective at the close of their proposed merger.

click here to view the release

distributed by